Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Recent studies have identified disrupted‐in‐schizophrenia‐1 (DISC1) as a strong genetic risk factor associated with schizophrenia. Previously, we have reported that a mutation in the second exon of the DISC1 gene [leucine to proline at amino acid position 100, L100P] leads to the development of schizophrenia‐related behaviors in mice. Glycogen synthase kinase‐3 (GSK‐3) is a serine/threonine protein kinase that interacts with the N‐terminal region of DISC1 (aa 1–220) and has been implicated as an important downstream component in the etiology of schizophrenia. Here, for the first time, we show that pharmacological and genetic inactivation of GSK‐3 reverse prepulse inhibition and latent inhibition deficits as well as normalizing the hyperactivity of Disc1‐L100P mutants. In parallel to these observations, interaction between DISC1 and GSK‐3α and β is reduced in Disc1‐L100P mutants. Our data provide genetic, biochemical, and behavioral evidence for a molecular link between DISC1 and GSK‐3 in relation to psychopathology and highlights the value of missense mutations in dissecting the underlying and complex molecular mechanisms of neurological disorders. Synapse, 2010. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Self-citationLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Self-citationDisruption of two novel genes by a translocation co-segregating with schizophrenia
Millar, J. K. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1415 · Cited by 1,254 · cited 1×
“3) translocation that cosegregates in a Scottish family with major mental illness, including schizophrenia, bipolar disorder, and major depression (Blackwood et al., 2001; Millar et al., 2000).”
BackgroundLisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010 · cited 2×
“…to the illness (over 130 genes have been reported to predispose to schizophrenia), important influence of environmental factors, neurodevelopmental defects, as well as dysfunction of different neurotransmitter systems (Harrison and Weinberger, 2005; Lisman et al., 2008; Ross et al., 2006).”
BackgroundSutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903 · cited 1×
“GSK-3 is unusual as a protein kinase as it is active under basal conditions (Stambolic and Woodgett, 1994; Sutherland et al., 1993; Woodgett, 1994) and is rapidly inhibited by diverse signals such as insulin, Wnts, Sonic Hedgehog (Shh), and Notch signaling pathways [reviewed in Jope and Roh, 2006;…”
BackgroundNoble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 4×
“, 2008), Alzheimer’s disease (Engel et al., 2006; Huang and Klein, 2006; Munoz-Montano et al., 1997; Noble et al., 2005) and schizophrenia (Beaulieu et al.”
BackgroundInfluentialDISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
Millar, J. K., Pickard, B. S., Mackie, S., James, R., Christie, S., Buchanan, S. R., Malloy, M. P., Chubb, J. E., Huston, E., Baillie, G. S., et al. (2005) · Science · doi:10.1126/science.1112915 · Cited by 648 · cited 7×
“VC 2010 WILEY-LISS, INC. interactors, such as cAMP-specific phosphodiesterase 4B (PDE4B) (Millar et al., 2005; Murdoch et al., 2007), NudE-like (NUDEL), and lissencephaly-1 (LIS1) (Taya et al., 2007), have been investigated in detail, and most of these were selected due to their neuronal function or/and involvement in…”
BackgroundInfluentialThe DISC locus in psychiatric illness
Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002106 · Cited by 542
Cited by
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
GSK-3: Functional Insights from Cell Biology and Animal Models
Kaidanovich-Beilin, O., & Woodgett, J. R. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00040 · Cited by 485
Self-citationLinking neurodevelopmental and synaptic theories of mental illness through DISC1
Brandon, N. J., & Sawa, A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3120 · Cited by 428
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
Eldar-Finkelman, H., & Martinez, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00032 · Cited by 354
DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness
Soares, D. C., Carlyle, B. C., Bradshaw, N. J., & Porteous, D. J. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200062k · Cited by 129
Metadata
- Authors
- Lipina, T. V., Kaidanovich‐Beilin, O., Patel, S., Wang, M., Clapcote, S. J., Liu, F., Woodgett, J. R., & Roder, J. C.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2010-12-28
- Volume
- 65
- Issue
- 3
- Pages
- 234-248
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2096891080
- Cited by
- 91
- References
- 17
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3. https://app.cochat.ai/papers/10.1002/syn.20839
- The paper
- Lipina, T. V., Kaidanovich‐Beilin, O., Patel, S., Wang, M., Clapcote, S. J., Liu, F., Woodgett, J. R., & Roder, J. C. (2011). Genetic and pharmacological evidence for schizophrenia‐related Disc1 interaction with GSK‐3. Synapse. https://doi.org/10.1002/syn.20839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.